Literature DB >> 28441698

Ambulatory arterial stiffness index and its role in assessing arterial stiffness in dialysis patients.

Wenjin Liu1, Jiajun Zhou, Jianping Chen, Meijuan Meng, Xiurong Li, Chaoqing Gao, Jianmei Zhou, Liang Wang, Zhuxing Sun, Hong Chu, Wei Fan, Youwei Bai, Junwei Yang.   

Abstract

OBJECTIVE: Ambulatory arterial stiffness index (AASI) is a parameter derived from ambulatory blood pressure (ABP) readings. It is calculated as 1 minus the linear slope of DBP on SBP. We tested its value in assessing arterial stiffness in dialysis patients.
METHODS: We performed a cross-sectional analysis of the baseline data from a cohort study. A total of 344 patients on maintenance hemodialysis from six tertiary hospitals were included. All patients underwent ABP monitoring and carotid-femoral pulse wave velocity (cfPWV) measurement. Clinical determinants of AASI were analyzed, and the ability of AASI for assessing arterial stiffness was compared with ambulatory pulse pressure (PP).
RESULTS: Multiple regression analysis revealed that ambulatory PP (β = 0.003), current smoker (β = -0.069), age (β = 0.003) and ambulatory SBP (β = 0.001) were independent determinants of AASI. Ambulatory PP correlates better with cfPWV than AASI (r = 0.28 for AASI and 0.59 for PP; P for difference: <0.001). When cfPWV was treated as a categorical variable, receiver operating characteristic curve analysis also showed a more potent predictive value of PP over AASI (area under the curve: 0.64 for AASI, 0.80 for PP; P for difference: <0.001). Net reclassification improvement and integrated discrimination improvement analysis demonstrated no added predictive value of AASI to PP (net reclassification improvement = -2.2%, P = 0.26; integrated discrimination improvement = 0.001, P = 0.51). Sensitivity analysis in patients with more ABP readings (≥49) yielded similar results.
CONCLUSION: For dialysis patients, AASI has very limited value in assessing arterial stiffness, whether used alone or added to PP. Our results suggest that this index should not be used as a surrogate marker of arterial stiffness for dialysis patients in future practice and studies.

Entities:  

Mesh:

Year:  2017        PMID: 28441698     DOI: 10.1097/HJH.0000000000001309

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  4 in total

1.  Association of betaine with blood pressure in dialysis patients.

Authors:  Lulu Wang; Mingming Zhao; Wenjin Liu; Xiurong Li; Hong Chu; Youwei Bai; Zhuxing Sun; Chaoqing Gao; Lemin Zheng; Junwei Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-25       Impact factor: 3.738

2.  Relationship between A1166C polymorphism of angiotensin II type 1 receptor gene and arteriosclerosis: A protocol for systematic review and meta-analysis.

Authors:  Zhongping Shi; Jun Wang; Shanjiang Chen; Haiyue Dai; Yiwei Huang
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

3.  Noninvasive markers of arterial stiffness and renal outcomes in patients with chronic kidney disease.

Authors:  Xinru Guo; Yisha Li; Ying Yang; Wenling Wang; Shuang Liang; Ying Zheng; Xiangmei Chen; Guangyan Cai
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-01       Impact factor: 3.738

4.  The Relationship Between Ambulatory Arterial Stiffness Index and Cardiovascular Outcomes in Women.

Authors:  Christopher J Boos; Lin Thiri-Toon; Christopher D Steadman; Sujata Khambekar; Andrew Jordan; John Paul Carpenter
Journal:  Cardiol Res       Date:  2021-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.